enGene Holdings Inc.ENGNNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | -100.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | -171.25% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +44.10% | +119.75% | +29.35% | +15.69% | +13.74% |
| Weighted Average Shares Diluted Growth | +44.10% | +119.75% | +29.35% | +15.69% | +13.74% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -55.95% | -61.95% | -56.06% | +194.19% | +115.79% |
| Inventory Growth | -100.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +257.84% | +206.07% | -2.51% | -7.99% | -28.83% |
| Book Value per Share Growth | +160.99% | +82.33% | -27.68% | -24.69% | -45.91% |
| Debt Growth | +155.90% | +2.48% | +2.74% | +26.24% | +27.07% |
| R&D Expense Growth | +98.78% | +254.27% | +105.06% | +95.47% | +181.40% |
| SG&A Expenses Growth | +73.66% | +65.19% | +13.60% | +12.36% | +9.03% |